Determining the Pharmacodynamic Impact of Vaginal and IM Progestins on the Cervix
Phase of Trial: Phase IV
Latest Information Update: 12 Jun 2015
Price : $35 *
At a glance
- Drugs Hydroxyprogesterone (Primary) ; Progesterone congeners
- Indications Preterm birth
- Focus Biomarker; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 03 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.